To determine the role of the glutamine transporter SLC1A5 during latent infection, the SLC1A5 specific inhibitor L-γ-Glutamyl-p-nitroanilide (GPNA) was used [29]. This evidence concerns the gene SLC1A5 and disease arising from reactivation of latent virus.